Patents by Inventor Rob Ellis

Rob Ellis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies against loricrin
    Patent number: 12455289
    Abstract: The present invention relates inter alia to the development of monoclonal antibodies against Loricrin and methods for determining whether a subject with melanoma has an increased risk of metastasis using said antibodies.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: October 28, 2025
    Assignee: AMLO Biosciences Limited
    Inventors: Penny Lovat, Marie Labus, Rob Ellis, Ashleigh McConnell
  • Monoclonal antibodies against Ambra-1
    Patent number: 12275780
    Abstract: The present invention relates inter alia to the development of monoclonal antibodies against Ambra-1 and methods for determining whether a subject with melanoma has an increased risk of metastasis using said antibodies.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: April 15, 2025
    Assignee: AMLO Biosciences Limited
    Inventors: Penny Lovat, Marie Labus, Rob Ellis, Ashleigh McConnell
  • BIOMARKERS FOR DISEASE PROGRESSION IN SQUAMOUS CELL CARCINOMA
    Publication number: 20220308059
    Abstract: The present invention relates inter alia to methods for determining whether a subject with squamous cell carcinoma (SCC) has an increased risk of metastasis. The invention further relates to methods of treating such subjects, diagnostic assays and kits. In certain embodiments, the invention relates to identifying whether a subject suffering from SCC has an increased risk of metastasis by determining the expression of Ambra-1 and p62 in a SCC tissue sample obtained from the subject.
    Type: Application
    Filed: May 1, 2020
    Publication date: September 29, 2022
    Inventors: Marie LABUS, Penny LOVAT, Rob ELLIS, Ashleigh MCCONNELL
  • MONOCLONAL ANTIBODIES AGAINST LORICRIN
    Publication number: 20210396758
    Abstract: The present invention relates inter alia to the development of monoclonal antibodies against Loricrin and methods for determining whether a subject with melanoma has an increased risk of metastasis using said antibodies.
    Type: Application
    Filed: November 4, 2019
    Publication date: December 23, 2021
    Inventors: Penny LOVAT, Marie LABUS, Rob ELLIS, Ashleigh MCCONNELL
  • MONOCLONAL ANTIBODIES AGAINST AMBRA-1
    Publication number: 20210324059
    Abstract: The present invention relates inter alia to the development of monoclonal antibodies against Ambra-1 and methods for determining whether a subject with melanoma has an increased risk of metastasis using said antibodies.
    Type: Application
    Filed: November 4, 2019
    Publication date: October 21, 2021
    Inventors: Penny LOVAT, Marie LABUS, Rob ELLIS, Ashleigh MCCONNELL
  • Axle adjustment apparatus
    Patent number: 6345832
    Abstract: An apertured track and brace system for mounting a slider for adjusting the weight distribution of a semi-trailer. The apertured track is adapted to be mounted to both a semi trailer and to a carriage carrying a rear axle tandem, while a single type of brace is adapted to link the apertured track to other elements operable to slidably longitudinally position the axle tandem relative to the semi trailer itself.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: February 12, 2002
    Assignee: Fleetmaster, Inc.
    Inventor: Rob Ellis